Published in Antimicrob Agents Chemother on August 01, 2001
The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket. J Med Chem (2009) 0.98
Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane transducing peptide conjugates targeted to primer binding site of HIV-1 genome. Virology (2007) 0.89
Comparative study of mechanisms of herpes simplex virus inactivation by sodium lauryl sulfate and n-lauroylsarcosine. Antimicrob Agents Chemother (2002) 0.89
Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection. Clin Med Insights Womens Health (2014) 0.79
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology (1995) 14.30
Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science (1986) 12.49
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS (1993) 10.84
Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (1986) 10.62
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature (1986) 8.36
Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA (1992) 6.99
HIV prevention: the need for methods women can use. Am J Public Health (1990) 5.91
AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science (1986) 5.58
Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods Cell Biol (1994) 5.17
Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc Natl Acad Sci U S A (1984) 4.66
A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med (1998) 4.35
Co-receptors for HIV-1 entry. Curr Opin Immunol (1997) 4.31
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54
Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol (1987) 2.84
Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J Virol (1998) 2.82
Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol (1997) 2.54
Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol (1997) 2.42
Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.41
Trends in sexual risk behaviors among high school students--United States, 1991-1997. MMWR Morb Mortal Wkly Rep (1998) 2.27
Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology (1997) 2.26
Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS (1993) 2.05
The acquisition of host-encoded proteins by nascent HIV-1. Immunol Today (1998) 1.99
Challenges for the development of female-controlled vaginal microbicides. AIDS (1994) 1.97
Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J Immunol Methods (1993) 1.96
A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res Hum Retroviruses (1994) 1.95
Maintenance of behavioral change in a cohort of homosexually active men. AIDS (1992) 1.77
An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation. J Immunol (1991) 1.70
Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution. Biochemistry (1981) 1.66
The protective effect of nonoxynol-9 against HIV infection. Am J Public Health (1994) 1.55
Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate. Antiviral Res (1999) 1.51
The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health (1994) 1.50
The effectiveness of barrier methods of contraception in preventing the spread of HIV. AIDS (1995) 1.36
A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses. Antimicrob Agents Chemother (1999) 1.35
Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol. Contraception (1994) 1.35
The inhibitory effect of spermicidal agents on replication of HSV-2 and HIV-1 in-vitro. J Antimicrob Chemother (1993) 1.30
Chemokine receptors and HIV. J Leukoc Biol (1997) 1.25
The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis. Proc Natl Acad Sci U S A (1992) 1.24
pH modification of the effects of detergents on the stability of enteric viruses. Appl Environ Microbiol (1979) 1.19
Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J Virol (1998) 1.18
HIV interactions with CD4: a continuum of conformations and consequences. Immunol Today (1992) 1.16
The spermicide nonoxynol-9 does not inactivate papillomavirus. Sex Transm Dis (1992) 1.16
In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses. J Clin Microbiol (2000) 1.15
Inter-relationship between gender relations and the HIV/AIDS epidemic: some possible considerations for policies and programmes. AIDS (1993) 1.10
How lysophosphatidylcholine inhibits cell-cell fusion mediated by the envelope glycoprotein of human immunodeficiency virus. Virology (1997) 0.98
Observations from the CDC. The urgent need for new HIV/STD prevention options for women. J Womens Health (1998) 0.98
The epidemiology of the acquired immunodeficiency syndrome in the 1990s. Emerg Med Clin North Am (1995) 0.94
Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases. Antimicrob Agents Chemother (2001) 0.91
Future contraceptives. Sci Am (1995) 0.89
Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin. Biochem Biophys Res Commun (1991) 0.85
Contraceptives of the future in the light of HIV infection. Aust N Z J Obstet Gynaecol (1994) 0.85
Why do homosexual men relapse into unsafe sex? Predictors of resumption of unprotected anogenital intercourse with casual partners. AIDS (1993) 0.83
Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.80
The first total synthesis of natural (+)-terpestacin, syncytium formation inhibitor. J Antibiot (Tokyo) (1998) 0.80
Clinical research with topical microbicides as a potential HIV prevention method. AIDS Read (2000) 0.79
Aurothiolates inhibit HIV-1 infectivity by gold(I) ligand exchange with a component of the virion surface. Virology (1993) 0.77
HIV 'cofactor' comes in for more heavy fire. Science (1993) 0.76
New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J Clin Microbiol (2004) 6.06
Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus. J Clin Microbiol (1998) 4.51
Bactericidal activity and pharmacology of cefazolin. Antimicrob Agents Chemother (1973) 3.26
Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (2000) 3.26
Development of conventional and real-time PCR assays for the rapid detection of group B streptococci. Clin Chem (2000) 2.86
Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid. J Infect Dis (1974) 2.81
Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun (1998) 2.20
Development of a PCR assay for identification of staphylococci at genus and species levels. J Clin Microbiol (2001) 2.17
Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol (2000) 2.10
Development of a PCR assay for rapid detection of enterococci. J Clin Microbiol (1999) 2.09
Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group. CMAJ (1990) 2.06
Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus-infected subjects. J Infect Dis (1998) 2.03
Cross-resistance of Pseudomonas to gentamicin and tobramycin. Antimicrob Agents Chemother (1972) 1.90
Diagnosing bacterial infectious diseases in one hour: an essential upcoming revolution. Infection (1995) 1.75
Species-specific and ubiquitous DNA-based assays for rapid identification of Staphylococcus epidermidis. J Clin Microbiol (1996) 1.70
Comprehensive microRNA expression profiling of the hematopoietic hierarchy. Proc Natl Acad Sci U S A (2010) 1.67
Tissue penetration of ciprofloxacin after single and multiple doses. Antimicrob Agents Chemother (1986) 1.64
Multiplex PCR assays for the detection of clinically relevant antibiotic resistance genes in staphylococci isolated from patients infected after cardiac surgery. The ESPRIT Trial. J Antimicrob Chemother (2000) 1.58
Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Antimicrob Agents Chemother (1992) 1.55
Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma. J Infect Dis (1999) 1.52
Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.49
T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J Virol (1998) 1.48
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms. J Antimicrob Chemother (1982) 1.46
Evidence for horizontal gene transfer in evolution of elongation factor Tu in enterococci. J Bacteriol (2000) 1.42
Pharmacokinetics of ciprofloxacin in elderly subjects. Pharmacotherapy (1986) 1.40
Characterization of a Tn5382-like transposon containing the vanB2 gene cluster in a Clostridium strain isolated from human faeces. J Antimicrob Chemother (2005) 1.38
Certain chromosomal regions in Streptomyces glaucescens tend to carry amplifications and deletions. Mol Gen Genet (1985) 1.38
Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. J Infect Dis (2001) 1.35
Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo. Rev Infect Dis (1981) 1.34
Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. J Hum Virol (2001) 1.33
Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens. Antimicrob Agents Chemother (1988) 1.31
Influence of single or multiple doses of gentamicin and netilmicin on their cortical, medullary, and papillary distribution. Antimicrob Agents Chemother (1979) 1.30
Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial. Pediatr Infect Dis J (1987) 1.29
Role of chemokines and formyl peptides in pneumococcal pneumonia-induced monocyte/macrophage recruitment. J Immunol (2001) 1.28
Diagnosing infections--current and anticipated technologies for point-of-care diagnostics and home-based testing. Clin Microbiol Infect (2010) 1.27
Antibiotic susceptibility profiles of 941 gram-negative bacteria isolated from septicemic patients throughout Canada. The Canadian Study Group. Clin Infect Dis (1992) 1.26
Influence of growth medium and supplement on growth of Haemophilus influenzae and on antibacterial activity of several antibiotics. J Clin Microbiol (1987) 1.25
Evaluating anxiety and depression in HIV-infected patients. J Pers Assess (1998) 1.25
Accumulation, release and subcellular localization of azithromycin in phagocytic and non-phagocytic cells in culture. Int J Tissue React (1994) 1.23
Characterization of a plasmid isolated from Branhamella catarrhalis and detection of plasmid sequences within the genome of a B. catarrhalis strain. Plasmid (1988) 1.20
Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats. Antimicrob Agents Chemother (1990) 1.20
Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots. Antimicrob Agents Chemother (1977) 1.20
Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin. Antimicrob Agents Chemother (1981) 1.20
Laboratory detection of group B Streptococcus for prevention of perinatal disease. Eur J Clin Microbiol Infect Dis (2004) 1.20
High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. Antimicrob Agents Chemother (2005) 1.19
Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J Virol (1998) 1.18
Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression. J Biol Chem (1998) 1.18
Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold labeling. Antimicrob Agents Chemother (1991) 1.17
Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin. Antimicrob Agents Chemother (1986) 1.16
In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses. J Clin Microbiol (2000) 1.15
Increased nephrotoxicity of gentamicin in pyelonephritic rats. Kidney Int (1985) 1.13
Heterogeneous genomic amplification in Streptomyces glaucescens: structure, location and junction sequence analysis. Mol Gen Genet (1989) 1.13
Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients. Antimicrob Agents Chemother (1986) 1.11
Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J Infect Dis (1998) 1.10
Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology (1999) 1.10
Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis due to Escherichia coli. J Infect Dis (1982) 1.08
Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling. Antimicrob Agents Chemother (1992) 1.07
Development of a rapid PCR assay specific for Staphylococcus saprophyticus and application to direct detection from urine samples. J Clin Microbiol (2000) 1.05
Ruminococcus gauvreauii sp. nov., a glycopeptide-resistant species isolated from a human faecal specimen. Int J Syst Evol Microbiol (2008) 1.04
The Streptomyces coelicolor A3(2) bldB region contains at least two genes involved in morphological development. J Gen Microbiol (1990) 1.04
Determination of ciprofloxacin in biological samples by reversed-phase high performance liquid chromatography. Ther Drug Monit (1986) 1.03
Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects. J Clin Microbiol (1998) 1.02
Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity. Antimicrob Agents Chemother (1994) 1.01
Neuraminidase from a bacterial source enhances both HIV-1-mediated syncytium formation and the virus binding/entry process. Virology (2001) 1.00
Development of a species-specific DNA probe for Moraxella (Branhamella) catarrhalis. Mol Cell Probes (1991) 1.00
Pharmacokinetics of ceftazidime in elderly volunteers. Antimicrob Agents Chemother (1985) 1.00
Development of a real-time PCR assay for the specific detection and identification of Streptococcus pseudopneumoniae using the recA gene. Clin Microbiol Infect (2011) 0.99
Autoradiography of tobramycin uptake by the proximal and distal tubules of normal and endotoxin-treated rats. Antimicrob Agents Chemother (1986) 0.98
Significant reduction in the incidence of phlebitis with buffered versus unbuffered cephalothin. Antimicrob Agents Chemother (1976) 0.98
Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice. Infect Immun (2001) 0.98
Selective filtration of antibiotics through collodion membranes. Antimicrob Agents Chemother (1973) 0.97
Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. J Infect Dis (1989) 0.97
Introduction to stem cell biology in vitro. Threshold to the future. Ann N Y Acad Sci (1999) 0.97
Isolation and biochemical characterization of Haemophilus species isolated simultaneously from the oropharyngeal and anogenital areas. J Clin Microbiol (1989) 0.95
Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System. J Clin Microbiol (1997) 0.95
Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy. Antimicrob Agents Chemother (1999) 0.94
Endotoxin increases the nephrotoxic potential of gentamicin and vancomycin plus gentamicin. J Infect Dis (1990) 0.94
Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin. Antimicrob Agents Chemother (1997) 0.94
Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity. Eur J Pharmacol (1996) 0.94
Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography. Antimicrob Agents Chemother (1988) 0.93
Modulation of cytokines and chemokines, limited pulmonary vascular bed permeability, and prevention of septicemia and death with ceftriaxone and interleukin-10 in pneumococcal pneumonia. J Infect Dis (2000) 0.93
Protection against Leishmania major challenge infection in mice vaccinated with live recombinant parasites expressing a cytotoxic gene. J Infect Dis (1998) 0.93
Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in rats. Antimicrob Agents Chemother (1994) 0.93
Protein binding of ceftriaxone: comparison of three techniques of determination and the effect of 2-hydroxybenzoylglycine, a drug-binding inhibitor in uremia. Ther Drug Monit (1986) 0.93
Benefit from high intrarenal levels of gentamicin in the treatment of E. coli pyelonephritis. Kidney Int (1986) 0.93
Clostridium lavalense sp. nov., a glycopeptide-resistant species isolated from human faeces. Int J Syst Evol Microbiol (2009) 0.93
Endotoxin-tobramycin additive toxicity on renal proximal tubular cells in culture. Antimicrob Agents Chemother (1991) 0.92
Intrarenal concentrations of ampicillin in acute pyelonephritis. Antimicrob Agents Chemother (1981) 0.92
EBV suppresses prostaglandin E2 biosynthesis in human monocytes. J Immunol (2000) 0.92
The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements. J Immunol (1998) 0.92
Epidemiological typing of Moraxella catarrhalis by using DNA probes. J Clin Microbiol (1993) 0.91
Difference in blister fluid penetration after single and multiple doses of ceftriaxone. Antimicrob Agents Chemother (1985) 0.91
Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases. Antimicrob Agents Chemother (2001) 0.91